The effects of cinnamtannin B1 on cell proliferation and glucose uptake of 3T3-L1 cells were examined. Cinnamtannin B1 promoted cell proliferation of 3T3-L1 adipocytes at a concentration range between 0.11-0.17 mM. The effect of cinnamtannin B1 on cellular 2-deoxy-D-[1-3 H] glucose uptake in differentiated 3T3-L1 adipocytes, following treatment with a 0.11 mM concentration of cinnamtannin B1 for 15, 30 and 60 minutes, was an increase in the glucose uptake from a basal value to 702.0, 1111.0 and 2226.0 cpm, respectively (p<0.005). The comparable glucose uptakes with insulin treatment were 660.0, 1039.0 and 2135.0 cpm, respectively. Wortmannin and cytochalasin B were found to inhibit cinnamtannin B1-stimulated glucose uptake, but sodium orthovanadate increased the glucose uptake.
Type 2 diabetes is characterized by insulin resistance in the major target tissues, coupled with insufficient insulin secretion; this leads to an impaired uptake and metabolism of glucose [1] .
Insulin resistance is defined as an inability of insulin to promote normal cellular glucose uptake at a given insulin concentration. In muscle cells and adipocytes, insulin stimulated cellular glucose transport is driven by the appearance of the insulin responsive glucose transporter, GLUT-4, at the plasma membrane [2] . The increasing knowledge of the biochemical and cellular alterations occurring in Type 2 diabetes mellitus has promoted the development of novel and potentially more effective therapeutic approaches to treat the disease.
The stem bark of the tropical plant Cinnamomum zeylanicum (kayu manis in the Malay dialect) has been used traditionally as a folk medicine in the treatment of diabetes. An ammoniacal extract of the polar compounds from cinnamon has been shown to enhance insulin activity [3] [4] , and an intensive study of C. burmanii showed that the insulin mimetic compound was a methylhydroxychalcone polymer [5] ; later this was identified as a proanthocyanidin type-A [6] . This compound, cinnamtannin B1, had been shown earlier to be active in inducing the differentiation of 3T3-L1 preadipocytes [7] . In this present communication we report the isolation and activity of cinnamtannin B1 on 3T3-L1 cells.
Cinnamtannin B1 prevented 3T3-L1 preadipocyte proliferation:
To determine the effect of cinnamtannin B1 in promoting cell proliferation of preadipocytes, 3T3-L1 preadipocytes were cultured in the presence of either 0.11 mM cinnamtannin B1, or a combination of cinnamtannin B1 and insulin, and then cell proliferation was measured at several times during the course of growth. The addition of either cinnamtannin B1 or insulin at the time of subculture prevented 3T3-L1 preadipocyte proliferation, as shown in Figure 1 . The results show that addition of cinnamtannin B1 at the time of subculture inhibited cell proliferation by blocking cell attachment. At day-3, cinnamtannin B1 inhibited cell proliferation by nearly 50%.
Figure 1:
Effect of insulin (Ins) and cinnamtannin B1 (Cb1) on cell proliferation of 3T3-L1 preadipocytes. These chemicals were added at the time of subculturing. Untreated cells were cultured under normal conditions, but supplemented with 10% fetal bovine serum (FBS) and 1% penicillin-streptomycin. Cell numbers were counted everyday using the trypan blue exclusion method. Results are means, ± SE, of three experiments.
Figure 2:
Effect of insulin (Ins) and cinnamtannin B1 (Cb1) on the proliferation of 3T3-L1 adipocytes (0.11 mM cinnamtannin B1, 100 nM insulin or a combination of 0.11 mM cinnamtannin B1 and 100 nM insulin were added to differentiated 3T3-L1 adipocytes). Cells numbers were counted using the MTT assay for 3, 24 and 48 hours. Results are means, ± SE, of three experiments.
Cinnamtannin B1 promoted 3T3-L1 adipocyte proliferation:
Nine day post induction preadipocytes, with a normal cell differentiation mixture, were treated with either 0.11 mM cinnamtannin B1 or insulin, or a combination of cinnamtannin B1 and insulin. In an initial experiment, the cells were treated with these compounds and assayed for cell proliferation using the MTT assay. It was found that cinnamtannin B1 promoted cell proliferation, but a combination of cinnamtannin B1 and insulin resulted in the highest cell growth, which was approximately twofold higher after 48 hours, with a cell density of 6.8x10 5 cell/mL. Interestingly, without insulin, cinnamtannin B1 was still active in promoting adipocyte proliferation ( Figure 2 ). In order to select a suitable concentration range of cinnamtannin B1 that can enhance cell proliferation, different concentrations of cinnamtannin B1 (0.06, 0.11, 0.17, 0.23 mM) were tested with 3T3-L1 adipocytes. The concentration of 0.17 mM exhibited the maximum effect for enhancing cell proliferation. Cell number increased 1.6-fold after 48 hours of incubation in comparison with the blank. However, when a higher dose of 0.23 mM was applied to the culture, the cell number was decreased ( Figure 3 ). This result could be used as an indicator of the concentration limit when the compound is applied for toxicity study. Based on these results, the effective concentration range of cinnamtannin B1 equivalent to the normal tested concentration of 100 nM insulin was between 0.11-0.17 mM. The combination of compounds (0.17 mM cinnamtannin B1 and 100 nM insulin) exhibited maximum cell growth that was approximately twofold at 48 hours. Cells were fully confluent with the cell density of 6.8 x 10 5 cells/mL after 48 hours of treatment. Glucose uptake: Frost and Lane [8] observed that upon stimulation of adipocytes with insulin, a membrane-associated intracellular pool of glucose transporters was translocated to the plasma membrane, thereby increasing the rate of glucose uptake. They claimed that the increased V max for sugar uptake in the presence of insulin was attributable to an increased number of glucose transporters at the cell surface. After incubation of the cells with 0.11 mM cinnamtannin B1, the radioactivity incorporated into the cells was analyzed. As shown in Figure 4 , cinnamtannin B1 significantly stimulated glucose uptake in 3T3-L1 adipocytes with increases in treatment time. At 15 minutes post treatment, the activity of cinnamtannin B1 was not significantly exhibited. The glucose uptake activity gradually increased with treatment time. After 60 minutes, there was a 1.5-fold increase in glucose uptake compared to the control. As expected, insulin stimulated glucose uptake similarly to that of cinnamtannin B1. The combination of cinnamtannin B1 with insulin demonstrated similar effects to the glucose uptake produced by either insulin or cinnamtannin B1 alone. These results suggest that cinnamtannin B1 might be acting mimetically to insulin. 
Wortmannin and cytochalasin B inhibited glucose uptake: Wortmannin is an inhibitor of PI3-kinase and leads to the inhibition of insulin dependent 2-deoxy-D-[1-
3 H] glucose uptake in 3T3-L1 adipocytes [9] . In order to observe the effect of wortmannin in the presence of cinnamtannin B1, the following experiment was conducted. Differentiated cells were washed and glucose-starved, as described in the materials and methods section. Wortmannin (5 μL) was added to give a final concentration of 500 nM. The wortmannin treated cells were left for 15 minutes prior to stimulation with cinnamtannin B1. The treatment with wortmannin alone was used as a control. The results showed that 2-deoxy-D-[1-3 H] glucose uptake induced by cinnamtannin B1 was inhibited by wortmannin ( Figure 5 ). The cells previously treated with wortmannin showed no effect on glucose uptake after stimulation with cinnamtannin B1. The results reflected the wortmannin inhibition activity in blocking PI3kinase, which in turn blocks the translocation of GLUT-4 to the plasma membrane. Another compound, cytochalasin B, is also known to block glucose uptake in cells. Cytochalasin B was found to be a competitive inhibitor of the glucose carrier activity [10] . Cinnamtannin B1 was also added to the cells before treatment with cytochalasin B. The result in Figure 5 showed that the cells lost their ability to stimulate 2-deoxy-D-[1-3 H] glucose uptake. Cinnamtannin B1 was not competitive in blocking the action of cytochalasin B and inhibiting glucose transport across the cell membrane.
Sodium orthovanadate stimulated glucose uptake:
To determine the specific activity of cinnamtannin B1 on glucose uptake, 3T3-L1 adipocytes were treated with sodium orthovanadate. Vanadate inhibits protein phosphotyrosine phosphatases and also activates insulin receptor β-subunit autophosphorylation. It was considered that vanadate stimulated glucose uptake in 3T3-Ll adipocytes [11] . Cells were initially incubated with sodium orthovanadate at a concentration of 5 mM. After 15 minutes, cinnamtannin B1 was added to the culture and after another 15 minutes, 2-deoxy-D-[1-3 H] glucose was added. The addition of cinnamtannin B1 produced an approximate two-fold increment in 2deoxy-D-[1-3 H] glucose uptake ( Figure 5 ) compared to the work of Paquet et al. [12] under the same conditions.
The active compound isolated from Cinnamomum zeylanicum was cinnamtannin B1, a proanthocyanidin type-A derivative. Previous studies [5] reported this insulin mimicker compound from cinnamon. The compound was first assumed to be a methylhydroxychalcone polymer (MHCP), but in the latest publication [6] , the compound was identified as a polyphenol type-A polymer. 3T3-L1 preadipocytes and 3T3-Ll adipocytes were used to investigate the effects of cinnamtannin B1 with regards to insulin functions in regulating the glucose transport system and upregulating the cells' overall functional activities. 3T3-Ll adipocytes are a stable monolayer of cells, which maintain high cell viability and hormonal responsiveness for extended periods of time [8] . This study and the report of others [3, 4] have shown that 3T3-Ll adipocytes were fully differentiated, particularly in responding to insulin (for example, sugar uptake can be acutely activated 15-20-fold by insulin). When investigating cell proliferation, cinnamtannin B1 did not produce any positive effect on proliferation of 3T3-L1 preadipocytes (Figure 1 ), but somehow showed an inhibitory activity on cell growth. The reason for this effect could be due to 3T3-L1 preadipocytes expressing low levels of insulin receptor, but high levels of insulin-like growth factor I (IGF-I) receptor; insulin appears to signal through the IGF-I receptor at the induction of differentiation [13] . Similar to insulin, at either low level or in the absence of insulin receptor, cinnamtannin B1 was not able to activate autophosphorylation of these receptors and hence failed to stimulate proliferation of preadipocytes.
On the other hand, it was found that cinnamtannin B1 promoted the proliferation of 3T3-L1 adipocytes. Exposure of 3T3-L1 adipocytes to cinnamtannin B1 increased cell numbers 24 hours after treatment (Figures 2 and 3) . These findings demonstrated that cinnamtannin B1 could promote the cell proliferation by mimicking insulin activity and subsequently promoting cell growth.
Interestingly, without addition of insulin, cinnamtannin B1 was still active in promoting cell proliferation [7] . Cinnamtannin B1 stimulated glucose uptake in 3T3-L1 adipocytes, this significantly increasing with time of exposure. At 15 hours post treatment, glucose uptake was not increased significantly and, by this time, activity was increasing only gradually. After 60 minutes, there was a significant increase by one and half times that of basal uptake. As expected, insulin stimulated glucose uptake was approximately similar to that of cinnamtannin B1. The combination of cinnamtannin B1 and insulin had a similar effect to that of either insulin or cinnamtannin B1 alone.
Vanadate is known to mimic insulin, stimulate glucose uptake and increase insulin receptor βsubunit phosphorylation (on tyrosine). This work investigated the possibility that vanadate might, in combination with cinnamtannin B1, affect the cells' glucose uptake. The result showed that the activity of vanadate in stimulating glucose uptake was not affected in the presence of cinnamtannin B1. The pathogenesis of Type 2 diabetes is complex, involving the progressive development of insulin resistance and a relative deficiency in insulin secretion, leading to overt hyperglycemia. In this work, it was found that cinnamtannin B1 showed its ability to mimic insulin in stimulation of glucose uptake, as presented in Figure 4 . In another report [14] , cinnamtannin B1 was found to be active in stimulating phosphorylation of the insulin receptor. The activity of cinnamtannin B1 on phosphorylation of the insulin receptor was blocked by wortmannin, the PI3-kinase inhibitor. This indicated the involvement of a common PI3-kinase-dependent pathway. The first step in the signaling transduction of cinnamtannin B1 action could be by binding to the insulin receptor (IR), which leads to autophosphorylation and activation of IR tyrosine kinase. Tyrosine acts by phosphorylating the IR. The phosphorylation of insulin receptor activated receptor phosphorylation of the endogenous substrates, such as insulin receptor substrates (IRS)-1 and -2. This mechanism results in an activation of PI3-kinase and mitogen-activated protein kinase (MAPK) pathways [1] . Since preadipocytes are lacking in insulin receptors, cinnamtannin B1 and insulin exhibited no effect on cell proliferation. The involvement of PI3kinase is a necessary process in glucose regulation [15] . The key step in this process is by recruiting glucose transporter 4 (GLUT-4) to the cell surface and thus increase glucose uptake into adipocytes. In this perspective, the fact that cinnamtannin B1 appeared to promote cell proliferation and differentiation, and to enhance glucose uptake, suggests that this compound could be an alternative phytochemical for antidiabetic medication.
Experimental
All tissue culture materials were from GIBCO (Grand Island, NY). Insulin, cytochalasin B, wortmannin, sodium orthovanadate, dexamethasone, 3-isobutyl lmethylxanthine (IBMX), and 3- Cell cultures: 3T3-L1 preadipocytes were purchased from ECACC, UK. Cell cultures were propagated at 37°C in a humidified atmosphere of 5% CO 2 in DMEM containing 10% fetal bovine serum, 1 % penicillin (10.000 U/mL) and 1% streptomycin (10.000 μg/mL). Cells were seeded at 2-8 x10 4 into either 96-well, 24-wellplates, or 25 cm 2 T-Flasks for differentiation. Induction of differentiation was performed two days post confluence. Cells were maintained in differentiation medium DMEM, 10% fetal bovine serum, 1% penicillin and streptomycin, 0.25 mM dexamethasone, 0.5 mM 1-isobutyl-3methylxanthine (IBMX), and 1μg/mL insulin for four days; medium was changed every two days. At day 4, the dexamethasone and IBMX were removed with insulin remaining on the cells for an additional two days. Differentiation was allowed to continue in DMEM supplemented with 10% fetal bovine serum.
Isolation of cinnamtannin B1:
The dried and powdered stem bark of Cinnamomum zeylanicum (750 g) was extracted in a Soxhlet extractor for 18 hours with n-hexane (2.5 L), and acetone (2.5 L), successively. The solvents were removed under reduced pressure in a rotary evaporator. The acetone extract was separated by vacuum liquid chromatography (7.5x 7.5 cm) on silica gel 230-400 mesh, eluting with EtOAc (1.5 L), acetone (2.5 L) and MeOH (1 L) to give fractions 1, 2 and 3, respectively. The combined fraction 3 was evaporated and separated by column chromatography (6x 60 cm) on silica gel (70-230 mesh), eluting with n-hexane: EtOAc (1:1) (300 mL), EtOAc (400 mL), acetone (700 mL) and MeOH (500 mL). The fractions were collected in test tubes (25 mL) and those fractions containing compounds with the same R f values were combined to give fractions 1-5, 6-20, and 21-44. The combined fractions 6-20 were separated by silica gel column chromatography by eluting with EtOAc and EtOAc: MeOH Cell counting: Cell numbers of 3T-L1 preadipocytes were determined microscopically using the trypan blue exclusion method. Cell suspensions were mixed with an equal volume of 0.1% (w/v) trypan blue solution and loaded into an improved Neubauer hemocytometer counting chamber. Cell viability was determined from the membrane intact (MI) cell index, as described by Simpson et al. [18] . MI cell index is the percentage of MI cells/ (MI+MD), where: MI= membrane intact cells, which excluded trypan blue dye, and MD= membrane damaged-cells which absorbed trypan blue dye.
Cell proliferation analysis:
Cell proliferation of 3T3-L1 preadipocytes was monitored by the tryphan blue exclusion method. Insulin (100 nM), cinnamtannin B1 (0.11 mM) and a combination of insulin and cinnamtannin B1 were added to complete medium at the time of subculture. Cell numbers were counted every day for four days. Cell proliferation of 3T3-L1 adipocytes was monitored by the 3-(4,5-dimethylthiazol-2-yl)-2, 5-diphenyltetrazolium bromide (MTT) assay. 3T3-L1 adipocytes were treated at day-9, after inducing with 0.25 mM dexamethasone, 0.5 mM 1-isobutyl-3-methylxanthine (IBMX), and 1μg/mL insulin. The experiment was allowed to proceed for 3, 24, and 48 hours at 37°C in a humidified 5% CO 2 atmosphere. At the end of these periods, supernatants were discarded and cells were washed two times with phosphate buffer saline (PBS), then 20 μL of MTT stock solution (5 mg/mL) was added to each well and the plates were further incubated for 4 hours at 37°C; 100 μL dimethyl sulfoxide (DMSO) was added to each well to solubilize the water-insoluble purple formazan crystals [19] . The absorbance was measured with a microplate reader (Dynatech MR5000) at 570 nm and the reference wavelength of 630 nm. 
Cell differentiation analysis:
Staining was carried out as described by Bennett et al. [20] . Two days post-confluence cells were treated with the inducer cocktails described in Table 1 . Eleven days post induction, the cells were stained with Oil-Red O to determine the degree of adipocyte differentiation.
Glucose uptake analysis:
The 3T3-L1 adipocytes were differentiated with 10 mL medium in a 25 cm 2 T-flask. Following pretreatment, after serum starving of differentiated 3T3-L1 adipocytes for 3 hours, adipocyte cells were washed twice and equilibrated for 30 minutes in 10 mL KRPH buffer (5 mM Na 2 HPO 4 , 20 mM HEPES, pH 7.4, 1 mM MgSO 4 , 1 mM CaCl 2 , 136 mM NaCl, and 4.7 mM KCl). Cinnamtannin B1 or insulin or a combination of insulin and cinnamtannin B1 were added 30 minutes prior to the addition of 2-deoxy-D-[1-3 H] glucose. Cytochalasin B (40 mM), 500 nM wortmannin and 5 mM sodium orthovanadate were added 15 minutes prior to the addition of the test compounds. Glucose uptake proceeded in radio labeled sugar (2-deoxy-D-[1-3 H] glucose, 0.025 μCi/mL) for the times indicated in the results. After the indicated time, the reaction was terminated by washing the cells, three times, in cold phosphate-buffered saline (pH 7.4). Cells were washed and lysed with 0.5 N NaOH/0.1% SDS. Samples from each lysate were counted using a liquid scintillation counter (Packard Tricarb 2700 TR/SL).
Uptake was routinely measured in triplicate with each experiment repeated at least twice.
Statistical analysis:
Descriptive statistics, such as the mean and standard error, were used to summarize the results. Where significant differences occurred, treatment groups were compared to controls using Student's t-test. Statistical analysis was calculated using Sigma Plot 8.0. Statistical significance was defined by p<0.05
